Solana Co — Director's Dealing 2021

Apr 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-04-01

Reporting Person: LaViscount Joyce N (CFO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-01	Class A Common Stock	A	5337	$0.00	Acquired	9576	Direct
2021-04-01	Class A Common Stock	A	2668	$0.00	Acquired	12244	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Employee Stock Option (Right to Buy)	$17.80	A	3490	Acquired	2031-04-01	Class A Common Stock (3490)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock award under the Issuer's 2018 Omnibus Incentive Plan.

F2: Grant to the Reporting Person of Restricted Stock Units under the Issuer's 2018 Omnibus Incentive Plan. The shares will vest on October 2, 2021.

F3: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of four (4) successive equal annual installments beginning on April 1, 2022.